Valneva SE (LTS:0OB3) Other Current Liabilities : €30.2 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Valneva SE Other Current Liabilities?

Valneva SE's other current liabilities for the quarter that ended in Mar. 2025 was €30.2 Mil.

Valneva SE's quarterly other current liabilities increased from Sep. 2024 (€24.6 Mil) to Dec. 2024 (€44.6 Mil) but then declined from Dec. 2024 (€44.6 Mil) to Mar. 2025 (€30.2 Mil).

Valneva SE's annual other current liabilities declined from Dec. 2022 (€184.0 Mil) to Dec. 2023 (€55.9 Mil) and declined from Dec. 2023 (€55.9 Mil) to Dec. 2024 (€44.6 Mil).

Valneva SE Other Current Liabilities Historical Data

The historical data trend for Valneva SE's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Other Current Liabilities Chart

Valneva SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

35.53

159.37

184.01

55.88

44.60

Valneva SE Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															34.18	24.50	24.61	44.60	30.21

Valneva SE Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Valneva SE Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Valneva SE's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (LTS:0OB3) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

VALN:USA INRLF:USA VLA:France AYJ:Germany AYJ0:Germany AYJ0:Germany AYJ:Germany AYJ:Germany AYJ:Germany AYJ:Bulgaria VLA:Austria

Address

6 Rue Alain Bombard, Saint-Herblain, FRA, 44800

Website

https://www.valneva.com

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Valneva SE Headlines

No Headlines